Lotus Tissue Repair
-
2010
Company Description
Lotus Tissue Repair develops an accelerating chronic wound healing technology for the treatment dermatologic conditions such as foot ulcers.
Lotus Tissue Repair is developing its proprietary recombinant human collagen Type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions.
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Founders:
Mark de Souza -
Company Website:
-
Company E-mail:
-
Company Address:
One Mifflin Place, Suite 400Cambridge, MAUnited States -
CEO:
- Mark de Souza
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits